Market Overview

McNicoll Lewis Vlak Downgrades Alnylam Pharmaceuticals, Inc. to Hold, Raises PT to $27.50

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for ALNY

DateFirmActionFromTo
Oct 2016Morgan StanleyDowngradesOverweightEqual-weight
Oct 2016Stifel NicolausMaintainsHold
Oct 2016Goldman SachsMaintainsNeutral

View More Analyst Ratings for ALNY
View the Latest Analyst Ratings

Posted-In: News Downgrades Analyst Ratings

 

Related Articles (ALNY)